Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 July 2023 | Story Leonie Bolleurs | Photo Stephen Collett
Prof Oliver Mutanga and Prof Melanie Walker
Prof Oliver Mutanga, one of the first PhD gradautes under the SARChI Chair in Higher Education and Human Development, pictured with his former supervisor, Prof Melanie Walker, during his first visit to the university after ten years.

Prof Oliver Mutanga, a University of the Free State (UFS) alumnus with a PhD in Development Studies and an experienced researcher focused on matters pertaining to disability, education, equality, and health issues, recently took up the position of Assistant Professor in the Graduate School of Education at the Nazarbayev University in Astana, Kazakhstan.

Prof Melanie Walker, Director of the SARChI Chair in Higher Education and HumanDevelopment (HEHD) at the UFS, invited Prof Mutanga to discuss his own research via an open webinar and to engage with members of her research group.

Prof Walker explained that she was delighted to host Dr Mutanga at the university, given his profile as an outstanding and internationally mobile early career researcher, from whom others in her group could learn. “Further, I very much wanted Dr Mutanga to speak about his own research, given its overall academic excellence, quality, and impact. Going forward, I am looking forward to developing this link with Dr Mutanga and his colleagues abroad around critical diversity studies,” she states.

Profs Walker and Mutanga have collaborated in the past to write articles for academic journals arising from his doctoral research. Examples include, ‘Towards a disability-inclusive higher education policy through the capabilities approach’ (published in the Journal of Human Development and Capabilities) as well as ‘Exploration of the academic lives of students with disabilities at South African universities: Lecturers’ perspectives’ (published in the African Journal of Disability).

Prior to joining Nazarbayev University, Prof Mutanga gained valuable research and development experience in various countries, including Zimbabwe, Botswana, South Africa, Norway, and the United Kingdom.

He has also received several accolades for his work, including the prestigious Marie Sklodowska Curie Postdoctoral Fellowship at the University of Oslo, Norway, and the Global Challenges Research Fellowship at University College London's Institute of Education.

A unique outlook on disability

In 2013, Prof Mutanga was part of the first cohort of PhD students under the SARChI Chair in Higher Education and Human Development. Recently, during his three-day visit to the UFS, he addressed the HEHD research group and an international academic audience during a hybrid seminar on the perceptions and experiences of disability within the Tembo Mvura communities of Northern Zimbabwe.

In his research for this paper, Prof Mutanga uses storytelling and in-depth interviews to offer a distinctive, community-based, and Southern interpretation of disability. By applying the capabilities approach and the ubuntu philosophy, his study presents a contrast to Western perceptions of disability that often emphasise individual limitations and differences based on physical and mental characteristics, which have the potential to both result in isolation and to understanding people as autonomous but isolated beings.

Within the Tembo Mvura communities, he discovered that disability is viewed through a lens of interconnectedness between individuals, their environment, and the spiritual world: “They recognise the inherent worth and dignity of all individuals, irrespective of their impairments,” found Prof Mutanga. Indeed, impairment of full personhood is understood as lacking in any of the three dimensions outlined above.

Thus, Prof Mutanga explored the complex interaction of identity, access to land, laws, and language, as well as labelling, highlighting how these factors shape perceptions and experiences of disability within these communities.

He is of the view that these findings will have implications for North-dominated disability discourse and for policy, practice, and research within indigenous contexts, such as the Tembo Mvura, where disability is uniquely perceived and experienced.

In addition to the hybrid seminar, Prof Mutanga led valuable sessions with the HEHD Research Group, where the PhD and postdoctoral fellows had the opportunity to workshop and refine various aspects of their current research papers and to engage in discussions around building their academic careers.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept